These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 22962435)

  • 1. Human TLR4 polymorphism D299G/T399I alters TLR4/MD-2 conformation and response to a weak ligand monophosphoryl lipid A.
    Yamakawa N; Ohto U; Akashi-Takamura S; Takahashi K; Saitoh S; Tanimura N; Suganami T; Ogawa Y; Shibata T; Shimizu T; Miyake K
    Int Immunol; 2013 Jan; 25(1):45-52. PubMed ID: 22962435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural analyses of human Toll-like receptor 4 polymorphisms D299G and T399I.
    Ohto U; Yamakawa N; Akashi-Takamura S; Miyake K; Shimizu T
    J Biol Chem; 2012 Nov; 287(48):40611-7. PubMed ID: 23055527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Asp299Gly polymorphism alters TLR4 signaling by interfering with recruitment of MyD88 and TRIF.
    Figueroa L; Xiong Y; Song C; Piao W; Vogel SN; Medvedev AE
    J Immunol; 2012 May; 188(9):4506-15. PubMed ID: 22474023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of functional D299G.T399I polymorphic variant of TLR4 depends more on coexpression of MD-2 than does wild-type TLR4.
    Prohinar P; Rallabhandi P; Weiss JP; Gioannini TL
    J Immunol; 2010 Apr; 184(8):4362-7. PubMed ID: 20212095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The attenuated inflammation of MPL is due to the lack of CD14-dependent tight dimerization of the TLR4/MD2 complex at the plasma membrane.
    Tanimura N; Saitoh S; Ohto U; Akashi-Takamura S; Fujimoto Y; Fukase K; Shimizu T; Miyake K
    Int Immunol; 2014 Jun; 26(6):307-14. PubMed ID: 24380872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MD-2-dependent human Toll-like receptor 4 monoclonal antibodies detect extracellular association of Toll-like receptor 4 with extrinsic soluble MD-2 on the cell surface.
    Tsukamoto H; Ihara H; Ito R; Ukai I; Suzuki N; Kimoto M; Tomioka Y; Ikeda Y
    Biochem Biophys Res Commun; 2013 Oct; 440(1):31-6. PubMed ID: 24021278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycyrrhizin and isoliquiritigenin suppress the LPS sensor toll-like receptor 4/MD-2 complex signaling in a different manner.
    Honda H; Nagai Y; Matsunaga T; Saitoh S; Akashi-Takamura S; Hayashi H; Fujii I; Miyake K; Muraguchi A; Takatsu K
    J Leukoc Biol; 2012 Jun; 91(6):967-76. PubMed ID: 22422925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stable transduction of bovine TLR4 and bovine MD-2 into LPS-nonresponsive cells and soluble CD14 promote the ability to respond to LPS.
    Sauter KS; Brcic M; Franchini M; Jungi TW
    Vet Immunol Immunopathol; 2007 Jul; 118(1-2):92-104. PubMed ID: 17559944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism regulating cell surface expression and activation of Toll-like receptor 4.
    Saitoh S; Miyake K
    Chem Rec; 2006; 6(6):311-9. PubMed ID: 17304555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The RP105/MD-1 complex is indispensable for TLR4/MD-2-dependent proliferation and IgM-secreting plasma cell differentiation of marginal zone B cells.
    Nagai Y; Yanagibashi T; Watanabe Y; Ikutani M; Kariyone A; Ohta S; Hirai Y; Kimoto M; Miyake K; Takatsu K
    Int Immunol; 2012 Jun; 24(6):389-400. PubMed ID: 22354914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran.
    Kim HM; Park BS; Kim JI; Kim SE; Lee J; Oh SC; Enkhbayar P; Matsushima N; Lee H; Yoo OJ; Lee JO
    Cell; 2007 Sep; 130(5):906-17. PubMed ID: 17803912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of TLR4/MD-2 complex in species-specific lipopolysaccharide-mimetic signal transduction by Taxol.
    Kawasaki K; Akashi S; Shimazu R; Yoshida T; Miyake K; Nishijima M
    J Endotoxin Res; 2001; 7(3):232-6. PubMed ID: 11581576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elucidation of the MD-2/TLR4 interface required for signaling by lipid IVa.
    Walsh C; Gangloff M; Monie T; Smyth T; Wei B; McKinley TJ; Maskell D; Gay N; Bryant C
    J Immunol; 2008 Jul; 181(2):1245-54. PubMed ID: 18606678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetraacylated lipid A and paclitaxel-selective activation of TLR4/MD-2 conferred through hydrophobic interactions.
    Resman N; Oblak A; Gioannini TL; Weiss JP; Jerala R
    J Immunol; 2014 Feb; 192(4):1887-95. PubMed ID: 24420921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipopolysaccharide-binding protein-mediated Toll-like receptor 4 dimerization enables rapid signal transduction against lipopolysaccharide stimulation on membrane-associated CD14-expressing cells.
    Tsukamoto H; Fukudome K; Takao S; Tsuneyoshi N; Kimoto M
    Int Immunol; 2010 Apr; 22(4):271-80. PubMed ID: 20133493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the Toll-like receptor 4 (TLR-4) variants on intima-media thickness and monocyte-derived macrophage response to LPS.
    Norata GD; Garlaschelli K; Ongari M; Raselli S; Grigore L; Benvenuto F; Maggi FM; Catapano AL
    J Intern Med; 2005 Jul; 258(1):21-7. PubMed ID: 15953129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The TLR4 D299G and T399I SNPs are constitutively active to up-regulate expression of Trif-dependent genes.
    Hold GL; Berry S; Saunders KA; Drew J; Mayer C; Brookes H; Gay NJ; El-Omar EM; Bryant CE
    PLoS One; 2014; 9(11):e111460. PubMed ID: 25365308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid A antagonist, lipid IVa, is distinct from lipid A in interaction with Toll-like receptor 4 (TLR4)-MD-2 and ligand-induced TLR4 oligomerization.
    Saitoh S; Akashi S; Yamada T; Tanimura N; Kobayashi M; Konno K; Matsumoto F; Fukase K; Kusumoto S; Nagai Y; Kusumoto Y; Kosugi A; Miyake K
    Int Immunol; 2004 Jul; 16(7):961-9. PubMed ID: 15184344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innate recognition of lipopolysaccharide by Toll-like receptor 4/MD-2 and RP105/MD-1.
    Miyake K; Ogata H; Nagai Y; Akashi S; Kimoto M
    J Endotoxin Res; 2000; 6(5):389-91. PubMed ID: 11521060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular TLR4/MD-2 in macrophages senses Gram-negative bacteria and induces a unique set of LPS-dependent genes.
    Shibata T; Motoi Y; Tanimura N; Yamakawa N; Akashi-Takamura S; Miyake K
    Int Immunol; 2011 Aug; 23(8):503-10. PubMed ID: 21712422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.